Back to search

Article

CB-5083 and luteolin synergistically induce apoptosis of bladder cancer cells via multiple mechanisms

2023-08-23

Abstract excerpt

<h4>Purpose: </h4> Bladder cancer (BC) is a common urological malignancy that still lacks of effective treatments. In recent years, valosin-containing protein (VCP) was emerging as potential target for the treatment of cancers. CB-5083 was a VCP inhibitor that has been evaluated in phase I clinical trials. However, drug-resistance and severe side effects hamper the application of CB-5083. Amounting evidence sugges...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6c695433-23d2-5c43-98b3-21d906b924ae
DOI
10.21203/rs.3.rs-3270847/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CB-5083 and luteolin synergistically induce apoptosis of bladder cancer cells via multiple mechanismsDOI 10.21203/rs.3.rs-3270847/v1
Select a neighboring publication to make it the new centre.